Researchers Resolved Adenosine Receptor Structures
Scientists mapped the binding structures of adenosine receptors A2AR and A2BR when bound to the dual-agonist MRS3997.
Updated on Sept. 23, 2026 in Biotech
Researchers have successfully visualized the cryo-electron microscopy structures of adenosine receptors A2AR and A2BR bound to the dual-agonist MRS3997. This study clarifies how the drug interacts with these receptors to potentially protect brain tissue from damage following ischemia.
Why it matters
Understanding the distinct binding orientations of MRS3997 helps explain how the drug functions as an agonist at two different receptor sites. This insight addresses a lack of pharmacological data and provides a foundation for designing more potent and selective neurological treatments.
Cryo-electron microscopy revealed that in A2AR, the 6-bromoindole group adopts a vertical conformation, while in A2BR, it extends laterally into a secondary pocket. Molecular dynamics simulations confirmed that the moiety samples both orientations within A2BR.
The players
MRS3997
This is a dual-agonist compound known for its role in protecting post-ischemic brain tissue during prolonged inflammation.
Adenosine receptors A2AR and A2BR
These are G protein-coupled receptors that play significant roles in regulating inflammatory responses and neurological functions.
The details
The study utilized mutagenesis experiments and simulations to confirm that while the adenine core binds in a conserved manner, the 6-bromoindole group interacts differently with each receptor. These findings provide a clear mechanism for the drug's activity during post-ischemic brain inflammation.
Timeline
September 23, 2026: Researchers published the structural analysis of MRS3997.
The Tech Race
This research follows the ongoing trajectory of the G protein-coupled receptor structural biology initiative to map complex human protein interactions. By detailing specific receptor binding sites, the work improves upon legacy models that often failed to distinguish between closely related receptor subtypes.
While this study is currently foundational, the mapping of these receptors could eventually lead to the development of more effective medications for stroke recovery and brain inflammation. Improved design of such agonists could minimize side effects compared to current, less selective therapeutic options.
The takeaway
The successful visualization of these receptors proves that subtle conformational differences can be exploited for drug design. Future medical advancements in neurological health will rely on this type of precise, molecular-level mapping.
Further reading
For more on the evolution of structural biology, explore the Biotech section.
More information
View the peer-reviewed research article for detailed structural data.
Source note: This article includes information reported by Nature.
